 |
|
Colon and Rectal Cancer Trial Results
6. Oxaliplatin-Based Combination Treatment Confirmed Effective in Colorectal Cancer That Has Progressed
(Posted: 06/01/2003) - Early results from this trial led to U.S. Food and Drug Administration approval of oxaliplatin as a treatment for patients with advanced colorectal cancer that had progressed after chemotherapy (second-line therapy). These final results substantiate the earlier data and provide more details.
7. Cetuximab (Erbitux®) Combo More Effective Than Cetuximab Alone in Colorectal Cancer
(Posted: 06/01/2003) - This large European study offers independent confirmation of earlier findings suggesting that cetuximab is effective against metastatic colorectal cancer and that the cetuximab/irinotecan combination is more effective than cetuximab alone.
8. Survival Rates Same for Black, White Colon Cancer Patients
(Posted: 08/22/2002) - Black patients with colon cancer did just as well as white patients after treatment with adjuvant (additional) chemotherapy, according to a study published in the August 7, 2002, issue of the Journal of the National Cancer Institute. The finding contrasts with several previous studies that have found poorer survival among blacks with colon cancer than among their white counterparts.
9. Aspirin May Reduce Risk of Colon Polyps
(Posted: 04/09/2002) - A daily baby aspirin reduced by 19 percent the risk that precancerous polyps (adenomas) in the colon would recur in patients who'd had a previous adenoma surgically removed, researchers reported April 7, 2002, at the American Association for Cancer Research annual meeting.
10. Laparoscopic Colon Cancer Surgery Offers Little Quality-of-Life Benefit
(Posted: 01/31/2002) - Laparoscopic colon cancer surgery appears to offer little quality-of-life benefit compared to standard colon cancer surgery, according to the January 16, 2002, issue of the Journal of the American Medical Association. Whether laparoscopic surgery boosts survival, however, remains to be seen.
< Previous 1 2 3 4 Next >
|
|
|
